spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Kloeckner Pentaplast Announces Plans for New Lamination Facility

Kloeckner Metals

A state-of-the-art system will be used to produce laminated pharmaceutical films

Montabaur, Germany – June 7, 2016 – The Klöckner Pentaplast Group announced plans today to expand its high-barrier film lamination and coating capacities to reinforce the company’s commitment to the global pharmaceutical and medical industries. Beginning in early 2017, Klöckner Pentaplast will use a state-of-the-art system to produce Aclar® laminated pharmaceutical films from its site in Montabaur, Germany, a trusted source of high quality kp films for many industries. The new Montabaur line will be fully operational for the entire kp Pentapharm® Aclar® product range by the end of 2017.

As a result of this investment, the Klöckner Pentaplast facility in Bern, Switzerland will also have added capacity available to produce PVdC-coated high-barrier pharmaceutical films, while continuing to be a backup site for Aclar® lamination. The plan strengthens kp’s dedication to its global packaging customers by providing improved customer service and security of supply from multiple sites under a global DMF.

“This capacity expansion is part of Klöckner Pentaplast’s long-term strategy to leverage our global footprint to maximize improvements across the value chain, with a focus on being even more responsive to our pharmaceutical customers’ needs now and in the future,“ says Markus Pischulti, Business Director, Pharmaceutical Films EMEA.

About Klöckner Pentaplast Group

The Klöckner Pentaplast Group is a global leader in providing packaging, printing and specialty solutions serving the pharmaceutical, medical device, food, beverage and card markets among others. With a broad portfolio of rigid plastic films and services powered by innovation, Klöckner Pentaplast plays an integral role in the customer value chain by marketing and protecting product integrity, safety, consumer health and ultimately, brand reputation.

Klöckner Pentaplast continuously earns high EcoVadis ratings, indicating the company’s commitment to Corporate Social Responsibility throughout its global operations. kp’s practices rank in the top 8% of suppliers within the respective industry classification of plastics manufacturing and in the top 12% of over twenty thousand suppliers evaluated by EcoVadis. In benchmark comparison within the plastics manufacturing industry, kp is ahead of the industry average in all four areas assessed: Environment, Labor Practices, Fair Business Practices, and Responsible & Sustainable Procurement. Klöckner Pentaplast is among the top 5% of suppliers assessed in industry classification for Environmental Practices and in the top 9% of suppliers assessed in respective industry classification of Fair Business Practices. Visit www.kpfilms.com.
phone 01132 540 711
email enquiries@kloeckner.com
web www.kloecknermetalsuk.com/
email Kloeckner Metals UK, Valley Farm Road, Stourton, Leeds, LS10 1SD, UK
 
Print this page
Send to a friend
   
spacer
News and Press Releases

IONTAS to Generate Antibodies using Mammalian Display Technology for a Global Biopharma

Cambridge, UK, 22 January 2018: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, announced today that it has signed an agreement with Sanofi to discover antibodies using IONTAS’ proprietary Mammalian Display Technology.
More info >>


White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

Industry Events

3rd Annual Inhalation & Respiratory Drug Delivery Congress

8-9 May 2018, London, UK

Oxford Global are proud to present our hugely popular 3rd Annual Inhalation & Respiratory Drug Delivery Congress, 8th – 9th May 2018, London, UK. Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will gather for over 20 presentations and case studies focused on the key issues in inhalation and respiratory drug delivery.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement